Industry News

Eisai Inc. has added 24,148 sf to its 85,000 sf of manufacturing facilities in Research Triangle Park, providing space for research labs, offices, manufacturing, packing, locker rooms, a cafeteria and 130 parking spaces. The development also includes raw materials storage in an off-site warehouse. Eisai is the U.S. Pharmaceutical division of Esai Co. Ltd. of Japan and manufactures Aricept and Aciphex. Esai currently employs 130 people at the RTP facility.

Norak Bioscience Inc. is planning to triple the size of its facilities inResearch Triangle Park. Currently leasing 3,000 sf in RTP's BD Technologies Incubator, Norak's relocation anticipates adding up to 25 new employees and occupying 9,000 sf. Norak creates screening tools for drug discovery.

In the last year Wyeth-Lederle Vaccines and Pediatrics (a division of Wyeth-Ayerst Laboratories) has completed construction of a 115,000-sf manufacturing facility for new vaccine components, as well as new production, warehousing, administrative and central utilities buildings.

Microsoft Corp., headquartered near Seattle in Redmond, has selected Chicago-based Jones Lang LaSalle to handle all new leases, terminations, and renewals for the software maker’s leased office space, which totals approximately eight million sf around the world. The contract to consolidate all leasing functions with Jones Lang LaSalle is expected to be worth $3- to $5-million annually to the real estate company. Microsoft’s headquarters and other space the company uses around Seattle are not included in the contract.

CryoLife Inc. has completed the build-out of its 7,500-sf facility for the manufacture of BioGlue, a surgical adhesive being commercially rolled out in domestic and overseas markets. The manufacturing facility is located at CryoLife's headquarters and labs in suburban Atlanta.